Management of bee-sting anaphylaxis.
A retrospective case analysis of 101 adverse reactions to bee-stings and a prospective questionnaire analysis of the proposed management by local medical practitioners and resident hospital staff members of three hypothetical bee-sting reactions has revealed that understanding of the use of adrenaline in patients with reactions to bee envenomation is confused with regard to the indications for its use, dosage and route; that corticosteroid agents are used or are recommended too frequently, sometimes as the sole therapeutic agent; and that there is a lack of awareness of the need for volume replacement in hypotensive shocked patients. These conclusions highlight the urgent need for a greater understanding of the optimal forms of management for patients with acute anaphylactic reactions to bee envenomation.
Gupta
S
S
Flinders Medical Centre, Bedford Park, SA.
O'Donnell
J
J
Kupa
A
A
Heddle
R
R
Skowronski
G
G
Roberts-Thomson
P
P
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D000328:Adult; D000707:Anaphylaxis / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D000818:Animals; D001516:Bees; D002648:Child; D004837:Epinephrine / Q000627:therapeutic use*; D005194:Family Practice; D005260:Female; D006801:Humans; D007299:Insect Bites and Stings / Q000188:drug therapy* / Q000503:physiopathology; D007396:Internship and Residency; D008297:Male; D012189:Retrospective Studies; D011795:Surveys and Questionnaires
D000305:Adrenal Cortex Hormones; D004837:Epinephrine